Mutual Of America Capital Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Mutual Of America Capital Management LLC

$9.32 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$26.42 - $47.12 $6,287 - $11,214	238 Added 12.68%	2,115 $56,000
Q2 2022 Aug 10, 2022	BUY	$41.26 - $51.35 $9,902 - $12,324	240 Added 14.66%	1,877 $83,000
Q1 2022 May 02, 2022	BUY	$44.58 - $52.6 $3,789 - $4,471	85 Added 5.48%	1,637 $81,000
Q4 2021 Feb 03, 2022	BUY	$45.82 - $56.9 $687 - $853	15 Added 0.98%	1,552 $79,000
Q3 2021 Nov 10, 2021	SELL	$43.79 - $55.78 $5,298 - $6,749	-121 Reduced 7.3%	1,537 $86,000
Q2 2021 Aug 06, 2021	BUY	$36.86 - $44.5 $4,054 - $4,895	110 Added 7.11%	1,658 $71,000
Q1 2021 May 13, 2021	BUY	$40.32 - $50.97 $3,830 - $4,842	95 Added 6.54%	1,548 $65,000
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $2,086 - $2,567	-50 Reduced 3.33%	1,453 $68,000
Q3 2020 Nov 13, 2020	BUY	$37.02 - $51.28 $37,427 - $51,844	1,011 Added 205.49%	1,503 $64,000
Q2 2020 Aug 06, 2020	BUY	$43.24 - $55.02 $2,118 - $2,695	49 Added 11.06%	492 $24,000
Q1 2020 May 11, 2020	BUY	$34.37 - $60.07 $2,818 - $4,925	82 Added 22.71%	443 $20,000
Q4 2019 Feb 11, 2020	SELL	$54.32 - $64.31 $651 - $771	-12 Reduced 3.22%	361 $22,000
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $106 - $119	2 Added 0.54%	373 $21,000
Q2 2019 Aug 12, 2019	BUY	$46.61 - $58.45 $3,495 - $4,383	75 Added 25.34%	371 $21,000
Q1 2019 May 13, 2019	BUY	$38.66 - $51.82 $811 - $1,088	21 Added 7.64%	296 $15,000
Q4 2018 Feb 12, 2019	BUY	$36.72 - $67.73 $2,386 - $4,402	65 Added 30.95%	275 $11,000
Q3 2018 Nov 13, 2018	BUY	$66.65 - $83.86 $11,930 - $15,010	179 Added 577.42%	210 $15,000
Q2 2018 Aug 09, 2018	BUY	$51.25 - $76.62 $1,588 - $2,375	31 New	31 $2,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Account